Researchers report findings from the ACCORD trial that evaluated the relationship of a blood pressure polygenic risk score with cardiovascular outcomes in individuals with type 2 diabetes.
Investigators compare the effects of contraceptive agents containing estradiol valerate plus dienogest, ethinylestradiol plus dienogest, or dienogest alone on the suppression of pituitary and ovarian activity.
Investigators sought to determine if an association existed between weight change and major cardiovascular outcomes among patients with type 2 diabetes.
Investigators evaluated the effect of gender-affirming hormone therapy on markers associated with systemic, endothelial, or adipose tissue-related inflammation, as well as platelet activation and coagulation.
Researchers conducted a randomized control trial to identify glycemic outcomes following the implementation of a lifestyle intervention program among postpartum women.
Cognitive issues are often reported by people with hypoparathyroidism, but there has been limited study data to link the two. Researchers analyzed the potential association.
Numerous people on thyroid replacement therapy for hypothyroidism describe symptom such as persistent ‘brain fog.’ Researchers aimed to better understand what other issues ‘brain fog’ may be related to.
Researchers hypothesized that a rising number of thyroid cancer rates in adults with obesity in may also imply an increase in thyroid cancer rates in children.
Investigators studied whether cardiovascular disease in people with type 1 diabetes was linked to long-term glycemic control patterns.
Studies show a link between depression and osteoporosis. Researchers investigated whether osteoporosis drugs contributed to depression and anxiety.
